Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure
NCT: NCT06689553 · TERMINATED
広告
NCT識別子NCT06689553
ステータスTERMINATED
開始日2025-09-28
完了2026-05-05
SponsorParagate Medical LTD (INDUSTRY)
First posted
Last updated
概要
The study aims to assess the feasibility, safety, tolerability and functionality of a percutaneously delivered automated continual fluid removal System in up to 8 patients with Heart Failure (HF) and diuretic resistance. Intervention: Implanted absorption chamber, connected to an external pump. Follow up: 6 months post activation.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。